May 2026
You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedSCI Pharmtech Market Share Analysis for May 2026
"旭富製藥 － 發展無限，潛力無窮之上市公司 本公司為逾百年歷史之瑞士Siegfried 集團，於民國76年在台灣所投資創設，從事中間體、原料藥及特用化學品之研發、生產及行銷，產品主要外銷歐、美、日醫藥大廠，品質深受客戶肯定。本公司具有優異之經營團隊使得本公司業績逐年成長，並於93年掛牌上市。 本公司建立起以下之核心生產技術及市場優勢，提供專才學以致用與一展所長之工作環境。
(一)核心生產技術： 1.化學合成技術 2.製程放大技術 3.GMP建廠技術 4.GMP生產技術 5.GMP品管系統技術... More
SCI Pharmtech (including company regionals)
See more website traffic and engagement information- sci-pharmtech.com.tw
SCI Pharmtech Revenue up to May 2026 is 50M - 75M
revenue generated by SCI Pharmtech top domains
SCI Pharmtech top domains revenue over 3 years
Revenue for SCI Pharmtech top domains
Total visits to SCI Pharmtech's top domains
Understand SCI Pharmtech market share and potential market reach.
Total visits last 3 months
Subsidiaries Breakdown
Avg. visit duration in SCI Pharmtech's top domains
Analyze SCI Pharmtech engagement metrics.
Average visit duration last 3 months
Subsidiaries Breakdown
Avg. pageviews on SCI Pharmtech's top domains
See how SCI Pharmtech keep users engaged, nurture their interest, and encourage them to take the next step.
Average page views last 3 months
Subsidiaries Breakdown
